半夏泻心汤及其加减方治疗溃疡性结肠炎患者的临床观察

来源 :中国医药指南 | 被引量 : 0次 | 上传用户:liongliong571
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 评价半夏泻心汤及其加减方用于治疗溃疡性结肠炎患者的临床预后效果,为溃疡性结肠炎患者治疗工作提供参考,分析中医治疗优势。方法 选择医院2018年2月至2019年9月收治的溃疡性结肠炎患者84例。采取随机数表法将患者进行分组治疗。对照组42例患者采取常规西药治疗,试验组42例患者配合半夏泻心汤及其加减方治疗。对比两组患者的预后效果,包括治疗效果、安全性以及肿瘤坏死因子-α(TNF-α)、白细胞介素-1(IL-1)、脓血消失时间、腹痛消失时间、腹泻消失时间。结果 在临床疗效方面,试验组溃疡性结肠炎患者治疗“,”Objective To evaluate the clinical prognostic effect of Banxia Xiexin Decoction and its modified prescriptions in the treatment of patients with ulcerative colitis, provide a reference for the treatment of patients with ulcerative colitis, and analyze the advantages of traditional Chinese medicine. Methods A total of 84 patients with ulcerative colitis who were admitted to our hospital from February 2018 to September 2019 were selected. A random number table method was adopted to group patients with ulcerative colitis for treatment. The 42 patients in the control group were treated with conventional western medicine, and the 42 patients in the test group were treated with Banxia Xiexin Decoction and its modification. Compare the prognostic effect of the treatment of patients with ulcerative colitis in the control group and the experimental group, including the therapeutic effect, safety, and tumor necrosis factor-α (TNF-α) and interleukin-1 (interleukin, IL-1), disappearance time of pus and blood, abdominal pain and diarrhea. Results In terms of clinical efficacy, the efficacy of patients in the test group with ulcerative colitis after treatment was significantly higher than that of the control group, P<0.05; in terms of colonoscopy scores, the scores of the test group were significantly lower than those of the control group, P <0.05.The levels of TNF-α and IL-1 in the two groups were significantly lower than before treatment, and the levels of TNF-α and IL-1 in the test group were significantly lower than those in the control group, P <0.05; the disappearance time of pus and blood in the test group, the disappearance time of abdominal pain, and diarrhea was significantly shorter than that of the control group, P <0.05. The safety of medication between the groups was relatively close, P >0.05. Conclusion On the basis of conventional western medicine treatment, the treatment of ulcerative colitis with Banxia Xiexin Decoction and its modified decoction has a significant overall effect, which is more safe and effective, and promotes the improvement of patients\' symptoms and signs.
其他文献
目的 观察分析在人布鲁菌病抗体中进行虎红平板凝集试验以及试管凝集试验检测效果。方法 选择我疾控中心于2014年至2019年内收到的80例人布鲁菌病患者血清样品为研究对象,将所有样品按照检测方法的不同,分为对照组(40例,进行试管凝集试验检测)和观察组(40例,进行虎红平板凝集试验检测)。对两组样品在检测完成后的效果进行收集和分析。并对两组的敏感度、准确度、阳性率、阴性率以及布鲁菌检出率。结果 对照组进行试管凝集试验检测后敏感度80%,准确度为82.50%,观察组进行虎红平板凝集试验检测后敏感度为100%,
目的 评价糖尿病(2型)患者采取甘精胰岛素联合瑞格列奈治疗的可行性与降糖效果,为糖尿病患者临床用药提供参考。方法 选择医院2017年10月至2018年12月收治的2型糖尿病患者80例。结合不同的治疗方法将80例2型糖尿病患者进行分组,对照组以及试验组患者分别采取常规预混胰岛素降糖治疗、甘精胰岛素联合瑞格列奈治疗。对比两组2型糖尿病患者治疗后血糖达标时间、血糖控制效果、胰岛素用量以及低血糖发生率。结果 治疗后,试验组2型糖尿病患者血糖达标时间、胰岛素用量均少于对照组,血糖控制效果明显优于治疗前以及对照组,且